Annual ROE
-98.92%
-1.16%-1.19%
December 31, 2023
Summary
- As of February 8, 2025, ONCY annual return on equity is -98.92%, with the most recent change of -1.16% (-1.19%) on December 31, 2023.
- During the last 3 years, ONCY annual ROE has fallen by -12.39% (-14.32%).
- ONCY annual ROE is now -100.33% below its all-time high of 30.21 thousand%, reached on December 31, 2019.
Performance
ONCY ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-140.41%
-26.14%-22.88%
September 30, 2024
Summary
- As of February 8, 2025, ONCY quarterly return on equity is -140.41%, with the most recent change of -26.14% (-22.88%) on September 30, 2024.
- Over the past year, ONCY quarterly ROE has dropped by -15.33% (-12.26%).
- ONCY quarterly ROE is now -10300.74% below its all-time high of -1.35%, reached on March 31, 2000.
Performance
ONCY Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ONCY ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.2% | -12.3% |
| 3 y3 years | -14.3% | -70.3% |
| 5 y5 years | +65.8% | -70.3% |
ONCY ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -33.5% | at low | -125.2% | at low |
| 5 y | 5-year | -100.3% | at low | -125.2% | +86.4% |
| alltime | all time | -100.3% | +65.8% | <-9999.0% | +86.4% |
Oncolytics Biotech ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -140.41%(+22.9%) |
| Jun 2024 | - | -114.27%(+3.6%) |
| Mar 2024 | - | -110.34%(+4.4%) |
| Dec 2023 | -98.92%(+1.2%) | -105.64%(-15.5%) |
| Sep 2023 | - | -125.08%(+19.2%) |
| Jun 2023 | - | -104.91%(+18.5%) |
| Mar 2023 | - | -88.54%(+7.4%) |
| Dec 2022 | -97.76%(+31.9%) | -82.45%(+10.4%) |
| Sep 2022 | - | -74.69%(+9.7%) |
| Jun 2022 | - | -68.07%(+1.9%) |
| Mar 2022 | - | -66.81%(+7.1%) |
| Dec 2021 | -74.10%(-14.4%) | -62.36%(-10.9%) |
| Sep 2021 | - | -69.98%(-18.6%) |
| Jun 2021 | - | -85.96%(-14.9%) |
| Mar 2021 | - | -100.98%(+3.6%) |
| Dec 2020 | -86.53%(-100.3%) | -97.44%(-50.4%) |
| Sep 2020 | - | -196.39%(-18.3%) |
| Jun 2020 | - | -240.31%(-37.2%) |
| Mar 2020 | - | -382.91%(-62.9%) |
| Dec 2019 | 30.21 K%(<-9900.0%) | -1033.45%(+164.9%) |
| Sep 2019 | - | -390.06%(+31.9%) |
| Jun 2019 | - | -295.83%(+35.3%) |
| Mar 2019 | - | -218.69%(-2.4%) |
| Dec 2018 | -289.03%(+58.0%) | -223.98%(+8.0%) |
| Sep 2018 | - | -207.45%(+11.9%) |
| Jun 2018 | - | -185.44%(+9.8%) |
| Mar 2018 | - | -168.87%(+14.9%) |
| Dec 2017 | -182.92%(+26.9%) | -146.94%(+2.6%) |
| Sep 2017 | - | -143.18%(+5.1%) |
| Jun 2017 | - | -136.29%(+21.5%) |
| Mar 2017 | - | -112.20%(+23.0%) |
| Dec 2016 | -144.20%(+138.5%) | -91.19%(+35.0%) |
| Sep 2016 | - | -67.57%(+19.3%) |
| Jun 2016 | - | -56.62%(+2.5%) |
| Mar 2016 | - | -55.23%(+7.8%) |
| Dec 2015 | -60.47%(-57.3%) | -51.23%(-12.7%) |
| Sep 2015 | - | -58.69%(-23.5%) |
| Jun 2015 | - | -76.68%(-19.7%) |
| Mar 2015 | - | -95.44%(-19.5%) |
| Dec 2014 | -141.67%(+29.3%) | -118.55%(+2.4%) |
| Sep 2014 | - | -115.75%(+11.1%) |
| Jun 2014 | - | -104.21%(+18.0%) |
| Mar 2014 | - | -88.31%(+13.9%) |
| Dec 2013 | -109.54%(-55.2%) | -77.53%(-16.2%) |
| Sep 2013 | - | -92.56%(-14.7%) |
| Jun 2013 | - | -108.56%(-16.3%) |
| Mar 2013 | - | -129.68%(-2.2%) |
| Dec 2012 | -244.78% | -132.55%(+4.6%) |
| Sep 2012 | - | -126.69%(+21.4%) |
| Jun 2012 | - | -104.34%(+20.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2012 | - | -86.50%(+24.5%) |
| Dec 2011 | -101.58%(+78.1%) | -69.46%(+15.3%) |
| Sep 2011 | - | -60.23%(-10.4%) |
| Jun 2011 | - | -67.25%(-3.1%) |
| Mar 2011 | - | -69.43%(-21.2%) |
| Dec 2010 | -57.03%(+18.8%) | -88.06%(+9.5%) |
| Sep 2010 | - | -80.42%(+8.9%) |
| Jun 2010 | - | -73.83%(-15.0%) |
| Mar 2010 | - | -86.83%(-25.7%) |
| Dec 2009 | -48.00%(-77.7%) | -116.94%(-40.8%) |
| Sep 2009 | - | -197.47%(+1.2%) |
| Jun 2009 | - | -195.20%(+10.0%) |
| Mar 2009 | - | -177.39%(+52.4%) |
| Dec 2008 | -215.42%(+246.3%) | -116.41%(+28.4%) |
| Sep 2008 | - | -90.69%(+32.9%) |
| Jun 2008 | - | -68.22%(+34.1%) |
| Mar 2008 | - | -50.88%(+7.1%) |
| Dec 2007 | -62.20%(+30.3%) | -47.51%(-0.1%) |
| Sep 2007 | - | -47.56%(+5.9%) |
| Jun 2007 | - | -44.91%(+7.7%) |
| Mar 2007 | - | -41.69%(+10.3%) |
| Dec 2006 | -47.73%(+73.0%) | -37.80%(+12.2%) |
| Sep 2006 | - | -33.69%(-0.0%) |
| Jun 2006 | - | -33.70%(+1.1%) |
| Mar 2006 | - | -33.33%(+3.9%) |
| Dec 2005 | -27.59%(-11.7%) | -32.07%(+11.2%) |
| Sep 2005 | - | -28.85%(-7.6%) |
| Jun 2005 | - | -31.22%(-8.3%) |
| Mar 2005 | - | -34.05%(-11.2%) |
| Dec 2004 | -31.23%(-24.0%) | -38.36%(-14.0%) |
| Sep 2004 | - | -44.59%(+12.5%) |
| Jun 2004 | - | -39.64%(-18.8%) |
| Mar 2004 | - | -48.83%(+9.5%) |
| Dec 2003 | -41.09%(+8.4%) | -44.60%(-8.4%) |
| Sep 2003 | - | -48.71%(-4.4%) |
| Jun 2003 | - | -50.95%(+40.7%) |
| Mar 2003 | - | -36.21%(-2.8%) |
| Dec 2002 | -37.90%(+10.6%) | -37.26%(+3.6%) |
| Sep 2002 | - | -35.96%(-4.1%) |
| Jun 2002 | - | -37.50%(-0.8%) |
| Mar 2002 | - | -37.82%(+11.1%) |
| Dec 2001 | -34.28%(+27.0%) | -34.04%(+22.0%) |
| Sep 2001 | - | -27.91%(+22.0%) |
| Jun 2001 | - | -22.87%(+3.0%) |
| Mar 2001 | - | -22.21%(+21.4%) |
| Dec 2000 | -26.99%(+232.4%) | -18.30%(+16.1%) |
| Sep 2000 | - | -15.76%(+99.0%) |
| Jun 2000 | - | -7.92%(+486.7%) |
| Mar 2000 | - | -1.35% |
| Dec 1999 | -8.12% | - |
FAQ
- What is Oncolytics Biotech annual return on equity?
- What is the all time high annual ROE for Oncolytics Biotech?
- What is Oncolytics Biotech annual ROE year-on-year change?
- What is Oncolytics Biotech quarterly return on equity?
- What is the all time high quarterly ROE for Oncolytics Biotech?
- What is Oncolytics Biotech quarterly ROE year-on-year change?
What is Oncolytics Biotech annual return on equity?
The current annual ROE of ONCY is -98.92%
What is the all time high annual ROE for Oncolytics Biotech?
Oncolytics Biotech all-time high annual return on equity is 30.21 K%
What is Oncolytics Biotech annual ROE year-on-year change?
Over the past year, ONCY annual return on equity has changed by -1.16% (-1.19%)
What is Oncolytics Biotech quarterly return on equity?
The current quarterly ROE of ONCY is -140.41%
What is the all time high quarterly ROE for Oncolytics Biotech?
Oncolytics Biotech all-time high quarterly return on equity is -1.35%
What is Oncolytics Biotech quarterly ROE year-on-year change?
Over the past year, ONCY quarterly return on equity has changed by -15.33% (-12.26%)